Search

everythinglearnresearchcommunity

for

Search:↓

Finasteride and intense pulsed light effectively reduce unwanted facial hair in women, but may not be cost-effective.

Effective treatments for excessive hair growth in women include creams, laser therapy, and medications, with the choice depending on individual needs and potential side effects.

Finasteride effectively treats hair loss and enlarged prostate in men, with mild side effects.

Women with moderate body hair have higher levels of certain hormones and may benefit from treatment that increases sex hormone-binding protein.

The document concludes that hirsutism can be managed with various treatments tailored to the individual, potentially improving quality of life.

PCOS is a common hormonal disorder in women that can lead to serious health problems.

PCOS is a hormonal disorder causing symptoms like irregular periods and acne, and increases the risk of diabetes and heart disease.

The document says that early treatment of Acne Vulgaris is important to prevent scarring and that adult onset acne is common in women, often due to hormonal imbalances.

The document explains various skin conditions and their treatments.

The document concludes that treatments for female hair loss and excess body hair are available, but managing expectations is important.

The document concludes that PCOS in adolescents is complex and requires comprehensive care to manage its symptoms and associated health risks.

The report concludes that PCOS is mainly a condition of excess male hormones and its definition may change as new information is discovered.

Terazosin and finasteride effectively treat BPH, but combining them adds no extra benefit.

Experts recommend using evidence-based methods to diagnose and treat hirsutism, focusing on symptoms and underlying causes.

The document likely offers guidance on treating a woman's excessive hair growth, considering her symptoms and obesity.

Insulin resistance is a key factor in polycystic ovary syndrome, but genetics may also contribute.

Msx and Dlx genes are crucial for development, controlling cell behaviors like growth and differentiation through their roles as gene regulators.

The guidelines suggest a detailed approach to diagnosing and treating lupus, with a focus on regular check-ups, personalized medicine, and a range of drug options for different cases.

High levels of male hormones, insulin resistance, and obesity are closely linked and worsen polycystic ovary syndrome, but more research is needed to improve treatments.

The document concludes that the exact way alcohol causes harm to fetal development is unknown, but it significantly affects nutrient transport to the fetus and a safe level of alcohol during pregnancy is not determined.

Lower doses of treatments for hirsutism and acne in PCOS are effective and cause fewer side effects.

Minoxidil is the only FDA-approved topical drug for treating male or female pattern hair loss, and other medications like finasteride and dutasteride can also increase hair growth.

The document concludes that assessing hair follicle damage due to cyclophosphamide in mice involves analyzing structural changes and suggests a scoring system for standardized evaluation.

No treatment fully prevents hair loss from chemotherapy yet.

Spironolactone most effective for hirsutism, but has side effects.

Finasteride helps regrow hair and shrink prostate by reducing DHT, with some sexual side effects.

The document concludes that understanding sulfation biology is crucial for creating treatments due to its importance in biological functions and disease.

The conclusion is that managing androgen excess requires long-term treatment, including hormonal contraceptives and androgen blockers, with follow-up after six months.

Women with PCOS often have skin problems like excessive hair, acne, hair loss, and dark patches, which can be treated with hormonal and non-hormonal therapies.

The document concludes that early recognition and treatment of PCOS in adolescents is crucial for managing symptoms and long-term health risks.